Understanding the pharmaceutical patent system in Spain and Europe: a perspective from the need to take its protection-access tradeoff seriously

&
In Iván Vargas-Chaves & Daniel Alzate-Mora (eds.), Derecho y Salud: debates contemporáneos. Sincelejo: Editorial CECAR. pp. 73-86 (2020)
  Copy   BIBTEX

Abstract

As a result of the doctoral research developed by the main author (Vargas-Chaves, 2017), it was identified the evolution and perspectives of the pharmaceutical patent in the international trade system, as well as it future legal research needs in this topic, both immediate and long-term. Furthermore, a number of problems of public health were highlighted in which the patent-term-extension mechanisms have produced a lack of access to medicines.

Categories

Keywords

Reprint years

Links

PhilArchive

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Patent Funded Access to Medicines.Tom Andreassen - 2014 - Developing World Bioethics 15 (3):152-161.
The ‘access to medicines’ campaign vs. big pharma: Counter-hegemonic discourse change and the political economy of hiv/aids medicines.Thomas Owen - 2014 - Critical Discourse Studies 11 (3):288-304.
Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines.Joo-Young Lee & Paul Hunt - 2012 - Journal of Law, Medicine and Ethics 40 (2):220-233.
Incentivizing access and innovation for essential medicines: A survey of the problem and proposed solutions.Michael Ravvin - 2008 - Public Health Ethics 1 (2):110-123.
Raising the Barriers to Access to Medicines in the Developing World – The Relentless Push for Data Exclusivity.Sigrid Sterckx, Julian Cockbain & Lisa Diependaele - 2016 - Developing World Bioethics 17 (1):11-21.
Are pharmaceutical patents protected by human rights?Joseph Millum - 2008 - Journal of Medical Ethics 34 (11):e25-e25.
Fair Drug Prices and the Patent System.David B. Resnik - 2004 - Health Care Analysis 12 (2):91-115.
Asserting The Primacy of Health Over Patent Rights: A Comparative Study of the Processes that Led to the Use of Compulsory Licensing in Thailand and Brazil.Stephanie T. Rosenberg - 2014 - Developing World Bioethics 14 (2):83-91.
Pharmaceutical companies and access to medicines – social integration and ethical CSR resolution of a global public choice problem.Onyeka K. Osuji & Okechukwu Timothy Umahi - 2012 - Journal of Global Ethics 8 (2-3):139-167.
Pharmaceutical Companies and Global Lack of Access to Medicines: Strengthening Accountability under the Right to Health.Anand Grover, Brian Citro, Mihir Mankad & Fiona Lander - 2012 - Journal of Law, Medicine and Ethics 40 (2):234-250.
Global health impact: A basis for labeling and licensing campaigns?Nicole Hassoun - 2012 - Developing World Bioethics 12 (3):121-134.
Patents and Access to Drugs in Developing Countries: An Ethical Analysis.Sigrid Sterckx - 2004 - Developing World Bioethics 4 (1):58-75.
Patents and access to drugs in developing countries: An ethical analysis.Sigrid Sterckx - 2004 - Developing World Bioethics 4 (1):58–75.
Bodies of rights and therapeutic markets.João Biehl & Adriana Petryna - 2011 - Social Research: An International Quarterly 78 (2):359-386.
Bodies of Rights and Therapeutic Markets.João Biehl & Adriana Petryna - 2011 - Social Research: An International Quarterly 78 (4):359-386.

Analytics

Added to PP
2020-05-27

Downloads
251 (#77,527)

6 months
62 (#68,968)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references